Table of Content

Part 1. Introduction
1.1 Market definition
1.2 Key benefits
1.3 Market segment
Part 2. Methodology
2.1 Primary
2.2 Secondary
Part 3. Executive summary

Part 4. Market overview
4.1 Introduction
4.2 Market dynamics
4.2.1 Drivers
4.2.2 Restraints

Part 5. Global market for immunohistochemistry by product
5.1 Antibodies (primary antibodies, secondary antibodies)
5.1.1 Market size and forecast
5.2 Equipment (slide staining systems, tissue microarray systems, tissue processing systems, slide scanners, others)
5.2.1 Market size and forecast
5.3 Reagents (histological stains, blocking and fixation reagents, chromogenic substrates, fixation reagents, stabilizers, organic solvents, proteolytic enzymes, diluents)
5.3.1 Market size and forecast
5.4 Kits
5.4.1 Market size and forecast

Part 6. Global market for immunohistochemistry by application
6.1 Diagnostics (cancer, infectious diseases, autoimmune diseases, diabetes mellitus, nephrological diseases, others)
6.1.1 Market size and forecast
6.2 Drug testing
6.2.1 Market size and forecast

Part 7. Global market for immunohistochemistry by end user
7.1 Hospitals & diagnostic laboratories
7.1.1 Market size and forecast
7.2 Academia & research institutes
7.2.1 Market size and forecast
7.3 Others
7.3.1 Market size and forecast

Part 8. Global market for immunohistochemistry by region
8.1 Asia Pacific
8.1.1 Market size and forecast
8.2 Europe
8.2.1 Market size and forecast
8.3 North America
8.3.1 Market size and forecast
8.4 Middle East and Africa (MEA)
8.4.1 Market size and forecast
8.5 South America
8.5.1 Market size and forecast

Part 9. Key competitor profiles
9.1 Abcam plc
9.2 Agilent Technologies, Inc.
9.3 Bio SB, Inc.
9.4 Bio-Rad Laboratories, Inc.
9.5 Cell Signaling Technology, Inc. (CST)
9.6 Danaher Corporation
9.7 F. Hoffmann-La Roche AG
9.8 PerkinElmer, Inc.
9.9 The Merck Group
9.10 Thermo Fisher Scientific, Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

DISCLAIMER
ABOUT GEN CONSULTING COMPANY